| Biogen Switzerland AG - Tofidence 400 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 69925 | | 03 | | Tofidence 400 mg/20 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L04AC07 | | Tocilizumab | | 21.05.2025 | | |
|
| Composition |
| tocilizumabum 400 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 20 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Principe actif | Concentr. |
|---|
| Tocilizumabum | 400mg / 20ml |
| | | | Agents auxilliaires |
|---|
| Arginine Hydrochloride | | Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 80 | | Saccharum |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | | DDP | DDP | A | | Oui | | 006 | 4 | DDP | DDP | A | | Oui |
|
